Literature DB >> 28093682

Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.

Abdulla Watad1, Arsalan Abu Much1, Danielle Bracco1, Naim Mahroum1, Doron Comaneshter2, Arnon D Cohen2,3, Howard Amital4.   

Abstract

Ischemic heart disease (IHD) is a well identified cause of mortality in systemic lupus erythematosus (SLE) patients due to an accelerated premature atherosclerosis. We investigated the proportion of comorbid IHD among SLE patients derived from a large, national real-life database. Using data from the largest HMO in Israel, the Clalit Health Services, we selected for patients with SLE. These patients were compared with age and sex matched controls with regards to the proportion of IHD in a case-control study. Chi-square and t tests were used for univariate analysis, and a logistic regression model was used for multivariate analysis. The study included 5018 patients with SLE and 25090 age and sex-frequency matched controls. The prevalence of IHD in patients with SLE was increased in comparison to controls (11.3 and 3.1%, P < 0.001). In a multivariate analysis, SLE was associated with IHD (OR 3.77, 95% confidence interval 3.34-4.26). We have confirmed that SLE patients suffer a high prevalence of IHD. Our data supports that SLE is an independent risk factor for IHD. When evaluating by gender, the risk seems even more substantial in females. No significant difference was found in the risk of IHD in SLE among the difference socioeconomic strata.

Entities:  

Keywords:  Acute coronary syndrome; Cardiovascular risk; Comorbidity disease; Ischemic heart disease; Systemic lupus erythematosus

Mesh:

Year:  2017        PMID: 28093682     DOI: 10.1007/s12026-016-8884-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  48 in total

1.  Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

Authors:  H Amital; Z Szekanecz; G Szücs; K Dankó; E Nagy; T Csépány; E Kiss; J Rovensky; A Tuchynova; D Kozakova; A Doria; N Corocher; N Agmon-Levin; V Barak; H Orbach; G Zandman-Goddard; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

2.  Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Authors:  Yu Asanuma; Annette Oeser; Ayumi K Shintani; Elizabeth Turner; Nancy Olsen; Sergio Fazio; MacRae F Linton; Paolo Raggi; C Michael Stein
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

3.  Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease.

Authors:  Nicolas Vuilleumier; Guido Reber; Richard James; Danielle Burger; Philippe de Moerloose; Jean-Michel Dayer; Pascale Roux-Lombard
Journal:  J Autoimmun       Date:  2004-12       Impact factor: 7.094

4.  Risk factors for cardiovascular disease in systemic lupus erythematosus.

Authors:  E Svenungsson; K Jensen-Urstad; M Heimbürger; A Silveira; A Hamsten; U de Faire; J L Witztum; J Frostegård
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

5.  Lipid profile among girls with systemic lupus erythematosus.

Authors:  Daniele Machado; Roseli O S Sarni; Thaís T O Abad; Simone G L Silva; Eugênia J B Khazaal; Sonia Hix; Milena S G Correia; Fabíola I Suano-Souza; Claudio A Len; Maria Teresa R A Terreri
Journal:  Rheumatol Int       Date:  2015-11-16       Impact factor: 2.631

6.  Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus.

Authors:  Maureen McMahon; Jennifer Grossman; Brian Skaggs; John Fitzgerald; Lori Sahakian; Nagesh Ragavendra; Christina Charles-Schoeman; Karol Watson; Weng Kee Wong; Elizabeth Volkmann; Weiling Chen; Alan Gorn; George Karpouzas; Michael Weisman; Daniel J Wallace; Bevra H Hahn
Journal:  Arthritis Rheum       Date:  2009-08

7.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

Review 8.  Cardiovascular disease in autoimmune rheumatic diseases.

Authors:  Ivana Hollan; Pier Luigi Meroni; Joseph M Ahearn; J W Cohen Tervaert; Sam Curran; Carl S Goodyear; Knut A Hestad; Bashar Kahaleh; Marcello Riggio; Kelly Shields; Mary C Wasko
Journal:  Autoimmun Rev       Date:  2013-03-27       Impact factor: 9.754

9.  Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.

Authors:  Johanna Gustafsson; Iva Gunnarsson; Ola Börjesson; Susanne Pettersson; Sonia Möller; Guo-Zhong Fei; Kerstin Elvin; Julia F Simard; Lars-Olof Hansson; Ingrid E Lundberg; Anders Larsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2009-12-10       Impact factor: 5.156

10.  25-Hydroxy-vitamin D level may predict presence of coronary collaterals in patients with chronic coronary total occlusion.

Authors:  Yasemin Dogan; Bahadir Sarli; Ahmet Oguz Baktir; Serkan Kurtul; Mahmut Akpek; Omer Sahin; Huseyin Odabas; Engin Dondurmacı; Mehmet Ugurlu; Eyup Ozkan
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-09-28       Impact factor: 1.426

View more
  9 in total

1.  Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival.

Authors:  Abdulla Watad; Dennis McGonagle; Nicola L Bragazzi; Shmuel Tiosano; Doron Comaneshter; Yehuda Shoenfeld; Arnon D Cohen; Howard Amital
Journal:  Oncoimmunology       Date:  2019-03-24       Impact factor: 8.110

2.  The link between schizophrenia and hypothyroidism: a population-based study.

Authors:  Kassem Sharif; Shmuel Tiosano; Abdulla Watad; Doron Comaneshter; Arnon D Cohen; Yehuda Shoenfeld; Howard Amital
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

3.  Editorial: Cutting edge in systemic lupus erythematosus.

Authors:  David P D'Cruz; Annegret Kuhn
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE.

Authors:  Ola Nived; Ragnar Freyr Ingvarsson; Anna Jöud; Petrus Linge; Helena Tydén; Andreas Jönsen; Anders A Bengtsson
Journal:  Lupus Sci Med       Date:  2020-06

5.  Long-Term Hydroxychloroquine Therapy and Risk of Coronary Artery Disease in Patients with Systemic Lupus Erythematosus.

Authors:  Deng-Ho Yang; Pui-Ying Leong; Sung-Kien Sia; Yu-Hsun Wang; James Cheng-Chung Wei
Journal:  J Clin Med       Date:  2019-06-05       Impact factor: 4.241

6.  FMF Is Associated With a Wide Spectrum of MHC Class I- and Allied SpA Disorders but Not With Classical MHC Class II-Associated Autoimmune Disease: Insights From a Large Cohort Study.

Authors:  Abdulla Watad; Nicola Luigi Bragazzi; Mohammad Adawi; Yehuda Shoenfeld; Doron Comaneshter; Arnon D Cohen; Dennis McGonagle; Howard Amital
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

Review 7.  Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner.

Authors:  Irini Gergianaki; George Bertsias
Journal:  Front Med (Lausanne)       Date:  2018-05-29

8.  Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China.

Authors:  Haiyu Pang; Yicong Ye; Faming Ding; Mengtao Li; Xinglin Yang; Xufei Yang; Qian Wang; Dong Xu; Yunyun Fei; Lin Kang; Xiaofeng Zeng; Shuyang Zhang
Journal:  BMJ Open       Date:  2019-09-08       Impact factor: 2.692

9.  Venous thromboembolism events among RA patients.

Authors:  Ribhi Mansour; Shir Azrielant; Abdulla Watad; Shmuel Tiosano; Yarden Yavne; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Mediterr J Rheumatol       Date:  2019-03-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.